You are here

Cannabis cultivation business Symtomax have announced the launch of new CBD product Oral Tabs – featuring a revolutionary new method that allows for rapid delivery and controlled absorption, and since it does not have to be digested like oils or edibles, the products work quickly and effectively, on areas where it is needed. 

“The difference I feel from Oral Tabs over vaping my CBD is very noticeable. The effects are definitely faster and more prolonged.”
David F, UK

Symtomax’s advanced ‘layering’ technology means Users can consistently and repeatedly deliver accurate doses, without any special preparation, ensuring identical dosages and potency. Users knows better than anyone what they need, at the right time. Oral Tabs offers complete control and a very viable solution.

Click here to find out more about the Symtomax loan note and investor offer

Related articles: 

Stay ahead of the curve
Get the latest investment news and updates

Get the latest investment news, new opportunities, partnerships, and more. You can opt out anytime.

*Required info. We will never spam you and you can opt-out of our investor news anytime you choose. Check our privacy policy here

Frequently Asked Investor / Investment FAQs

If you have an questions about us or the investment products we offer, please don't hesitate to get in touch

Are there any guaranteed investments?

Yes, there are products that contain guarantees which are designed to provide peace of mind to first time investors but also appeal to the more cautious.

What risk do I have to take to generate a good return on my money?

Our goal is to offer investments suited to your desired risk profile. We recommend that you always consult with a qualified independent financial advisor before proceeding with any investments.

How are investments taxed?

Different products are taxed in different ways and at different times of the year. Although we do not offer tax advice, we do take into account the tax-efficiency of any investment products we offer.